Back to top
more

MiMedx Group (MDXG)

(Delayed Data from NSDQ)

$7.37 USD

7.37
832,074

-0.13 (-1.73%)

Updated May 3, 2024 04:00 PM ET

After-Market: $7.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for MiMedx Group, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 82 66 87 96 69
Receivables 54 44 41 45 32
Notes Receivable 0 0 0 0 0
Inventories 21 13 11 10 9
Other Current Assets 7 11 9 9 13
Total Current Assets 164 134 149 161 123
Net Property & Equipment 7 8 9 11 12
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 41 0 0 0 0
Intangibles 25 26 25 26 28
Deposits & Other Assets 0 0 0 0 0
Total Assets 239 171 188 202 167
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 9 9 7 9 9
Current Portion Long-Term Debt 0 0 0 0 4
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 32 33 33 49 53
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 5 2 2 1 1
Total Current Liabilities 46 44 42 59 67
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 48 49 48 48 62
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2 5 5 4 4
Minority Interest (Liabilities) 0 92 92 92 0
Total Liabilities 96 189 188 202 133
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 276 174 166 159 147
Retained Earnings -134 -192 -162 -151 -102
Other Equity 0 0 0 0 0
Treasury Stock 0 0 4 7 11
Total Shareholder's Equity 143 -18 0 0 34
Total Liabilities & Shareholder's Equity 239 171 188 202 167
Total Common Equity 143 -18 0 0 34
Shares Outstanding 146.23 113.67 112.10 111.00 110.70
Book Value Per Share 0.98 -0.16 0.00 0.00 0.31

Fiscal Year End for MiMedx Group, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,951 82 81 69 61
Receivables 57 54 49 49 45
Notes Receivable NA 0 0 0 0
Inventories 24 21 19 17 15
Other Current Assets 9 7 5 7 11
Total Current Assets 139 164 155 141 132
Net Property & Equipment 7 7 7 7 8
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges 39 41 0 0 0
Intangibles 32 25 25 25 26
Deposits & Other Assets 1 0 0 0 0
Total Assets 222 239 189 176 168
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable 10 9 9 8 8
Current Portion Long-Term Debt 1 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses 27 32 33 34 31
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities 4 5 2 2 2
Total Current Liabilities 42 46 44 44 41
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt 18 48 49 49 0
Long-Term Debt NA 0 0 0 49
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities 5 3 3 4
Minority Interest (Liabilities) NA 0 92 92 92
Total Liabilities 66 96 188 189 186
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 280 276 188 183 179
Retained Earnings -124 -134 -187 -196 -197
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity 156 143 1 -13 -18
Total Liabilities & Shareholder's Equity 222 239 189 176 168
Total Common Equity 100,155 143 1 -13 -18
Shares Outstanding 146.96 146.23 116.30 116.10 115.60
Book Value Per Share 681.51 0.98 0.01 -0.11 -0.16